A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG300) in Patients with Polycythemia Vera

  • Perkins, Andrew (Primary Chief Investigator (PCI))
  • Malherbe, Maturos (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date18/10/22 → 31/10/25

Keywords

  • clinical trial
  • Polycythemia Vera
  • Rusfertide
  • Chronic Myeloproliferative Disorders